Business Context and Reporting Period
SciSparc Ltd. filed a Form 6-K report for the month of June 2026, dated June 4, 2026. The filing serves to disclose a corporate event rather than routine financial results.
Key Event
The Company announced the completion of an acquisition by its subsidiary, NeuroThera Labs, of CliniQuantum. This information is based on a press release furnished as Exhibit 99.1.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a material event and does not contain a financial statement or earnings summary.
Material Changes
The primary material change is the completed acquisition of CliniQuantum by NeuroThera Labs. No comparative financial data or prior period analysis is included in this document.
Outlook and Risks
The filing does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies beyond the announcement of the acquisition completion.
Investor Verification Checklist
- Verify the terms and consideration paid for the CliniQuantum acquisition in the full press release (Exhibit 99.1).
- Confirm the strategic rationale and expected impact of the CliniQuantum acquisition on SciSparc's portfolio.
- Review subsequent filings for any financial impact or integration updates related to NeuroThera Labs.